BRIMARAFENIB
UNII GXS33OY2CB

Substance Identification & Data

This profile provides standardized clinical and technical data for Brimarafenib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GXS33OY2CB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1643326-82-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
GXS33OY2CB
CAS Registry Number
1643326-82-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRIMARAFENIB
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C24H17F3N4O4
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
USMWOBMHNWNPAP-FKBYEOEOSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
C173633
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
117807031
Unique identification number in the NCBI database of chemical substances.
INN ID
12863
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N(C(Nc1c(F)cc(F)c(F)c1)=O)[C@H]2[C@]3([C@@]2(Oc4c3cc(OC5=C6C(NC=C5)=NC(=O)CC6)cc4)[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brimarafenib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRIMARAFENIB

Common Names & Synonyms

BRIMARAFENIB [INN]
BRIMARAFENIB [WHO-DD]

Systematic Nomenclature

5-((2S,3S,4S)-3-(3-(2,4,5-TRIFLUOROPHENYL)UREA)-1-OXA-3,4-DIHYDRO-2H-NAPHTHALEN-6-YLOXY)-1,8-DIAZA-4,8-DIHYDRONAPHTHALEN-2(3H)-ONE
5-((2S,3S,4S)-3-(3-(2,4,5-TRIFLUOROPHENYL)UREIDO)-1-OXA-3,4-DIHYDRO-2H-NAPHTH-6-YLOXY)-1,8-DIAZA-4,8-DIHYDRO-2(3H)-NAPHTHALENONE
N-((1S,1AS,6BS)-1A,6B-DIHYDRO-5-((5,6,7,8-TETRAHYDRO-7-OXO-1,8-NAPHTHYRIDIN-4-YL)OXY)-1H-CYCLOPROPA(B)BENZOFURAN-1-YL)-N'-(2,4,5-TRIFLUOROPHENYL)UREA
N-((1S,1AS,6BS)-5-((7-OXO-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-4-YL)OXY)-1A,6B-DIHYDRO-1H-CYCLOPROPA(B)BENZOFURAN-1-YL)-N'-(2,4,5-TRIFLUOROPHENYL)UREA
UREA, N-((1S,1AS,6BS)-1A,6B-DIHYDRO-5-((5,6,7,8-TETRAHYDRO-7-OXO-1,8-NAPHTHYRIDIN-4-YL)OXY)-1H-CYCLOPROPA(B)BENZOFURAN-1-YL)-N'-(2,4,5-TRIFLUOROPHENYL)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus
NLM
PubChem Compound